Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
Titel:
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
Auteur:
Quinn, Dean Barnes, Christopher N. Yates, Wayne Bourdet, David L. Moran, Edmund J. Potgieter, Peter Nicholls, Andrew Haumann, Brett Singh, Dave